NEW
HAVEN, Conn., April 29,
2024 /PRNewswire/ -- Jumo Health—a global provider of
age-appropriate, culturally relevant medical education—today
announced that Kevin Aniskovich, the
Company's President and CEO, will be moderating a roundtable
discussion, "Why Authenticity and the Patient Voice is Critical
When Driving Diversity in Clinical Trials" at the Health Equity in
Clinical Trials Congress.
"We're proud to lead this round table
because health equity... is an essential component to our service
offering"
"While there has been much discussion on increasing
participation among traditionally under-represented communities in
clinical research, we continue to witness the same tactics deployed
in-market and hoping for a different outcome," shared Aniskovich.
"At Jumo Health, we believe education is the cornerstone of a
patient's clinical trial success. Through local community input, we
focus on elevating health literacy by sharing patient stories to
ensure our materials are authentic and relatable, address the
social determinants of health, and increase participation in
clinical trials. We are proud to lead this round table because to
us, health equity is more than a topic of discussion, it is an
essential component to our service offering and why we're trusted
by the world's largest companies," concluded Aniskovich.
The Health Equity in Clinical Trials Congress will be held in
Atlanta, Georgia on May 8-9, 2024. This event provides a platform for
a collaborative discussion among pharmaceutical, biotech and
various service providers to share current thinking around
strategies to improve access to clinical trials.
The roundtable discussion will allow patient advocates,
community activists, and pharmaceutical clients to share their
success stories on how their study teams are implementing diversity
initiatives to improve recruitment and retention. Panelists will
also discuss the importance of activating local community members
to help build trust. The roundtable will include the following
individuals:
- Kevin Aniskovich,
President & CEO, Jumo
Health
- Tony Wafford, President
& CEO, I Choose Life Foundation
- LaToya Bolds-Johnson,
Patient Advocate
- Erika Heiges, Associate
Director, Engagement Strategy Lead, Bristol-Myers Squibb
- Gwenn Oakes, Director,
Global Trial Optimization, Merck & Co.
In addition, the Congress will feature speakers from top
pharmaceutical and biotech companies who will share their unique
perspectives and experiences on how to make clinical trials more
accessible to people of all communities. To view the agenda and
register for the Second Annual Health Equity in Clinical
Trials Congress, visit
healthequityclinicaltrialcongress.com
To learn how Jumo Health is pioneering diversity in clinical
trials through a focus on health literacy and sharing real patient
experiences through authentic storytelling, visit
diversity.jumohealth.com to schedule a time to speak with a
representative about your trial needs.
About Jumo Health
Jumo Health develops
age-appropriate, culturally relevant, and relatable educational
resources for patients and caregivers. We have experience serving
diverse populations, covering more than 160 health topics across
80+ countries in 120+ languages. Our various digital, video, and
print offerings use highly visual elements and research-supported
health literacy strategies to ensure that everyone can understand
and act upon complex medical information. We do this through
familiar mediums—from comic books and animation, to virtual reality
experiences and authentic documentary-style patient stories—all
customized based on audience. Jumo Health collaborates globally
with more than 180 advocacy groups and community organizations to
promote access and to ensure unique patient experiences are
accurately represented.
JumoHealth.com
Media Contact
Dani Himelright
Dani@jumohealth.com
+1 (614) 284-6804
View original content to download
multimedia:https://www.prnewswire.com/news-releases/jumo-health-to-lead-a-roundtable-discussion-on-authenticity-and-the-patient-voice-at-the-annual-health-equity-in-clinical-trials-congress-302130146.html
SOURCE Jumo Health